Tenet Healthcare (THC)
(Delayed Data from NYSE)
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$165.84 USD
+1.17 (0.71%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $165.85 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth D Momentum A VGM
Zacks News
Why Tenet Healthcare (THC) Might Surprise This Earnings Season
by Zacks Equity Research
Tenet Healthcare (THC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tenet Healthcare (THC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
Tenet Healthcare (THC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 108.33% and 4.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Shape Tenet Healthcare's (THC) Q2 Earnings
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results are likely to reflect the impact of lower contribution of the Hospital segment to overall revenues. The results might partly benefit from a downtrend in operating expenses.
Analysts Estimate HCA Healthcare (HCA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Tenet Healthcare (THC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services
by Zacks Equity Research
Acadia Healthcare, Pediatrix Medical, Tenet Healthcare and Discover Financial Services are part of Zacks Industry Outlook article.
2 Top Hospital Stocks to Buy Despite Industry Headwinds
by Kaibalya Pravo Dey
Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised to win big with recovering patient volumes.
Implied Volatility Surging for Tenet Healthcare (THC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Tenet Healthcare (THC) Unit Ties Up to Boost Urology Services
by Zacks Equity Research
Tenet Healthcare's (THC) unit, USPI, signs a joint venture partnership with UUG to acquire ownership interests in the latter's 22 ambulatory surgery centers and concurrently assuring to develop these centers.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Tenet Healthcare (THC) Unit Conifer Offers Services to Brookwood
by Zacks Equity Research
Tenet Healthcare's (THC) unit Conifer inks an agreement with Brookwood Baptist Health to deliver enhanced revenue cycle services to four of the remaining hospitals of the latter across Central Alabama.
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Should iShares Russell 2000 Value ETF (IWN) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWN
Why Is Tenet (THC) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Encompass Health (EHC) Unveils Plan to Better Serve Texas
by Zacks Equity Research
Encompass Health (EHC) announces plans to construct a 60-bed inpatient rehabilitation hospital in Texas in a bid to more effectively cater to the health issues of the state.
Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
by Zacks Equity Research
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV